Netherlands fast bowler Vivian Kingma has been suspended for three months after returning a positive test for a recreational substance. The 30-year-old pleaded guilty to the offence, proving that the drug had been consumed out-of-competition. Kingma's sample, collected after the Netherlands' ODI against the United Arab Emirates on May 12 at Utrecht in the ICC Men's Cricket World Cup League 2, was found to contain Benzoylecgonine, a metabolite of cocaine and a Substance of Abuse under the ICC Anti-Doping Code. The sanction is from August 15. The three-month suspension can be cut short to a month if Kingma successfully undergoes an ICC-approved treatment programme. Aside from the suspension, all his records from the UAE ODI have been revoked. This suspension includes two ODIs against Nepal and Scotland, where Kingma had picked two wickets for 122 runs in total. It also encompasses a T20I against Scotland, where he bowled only three balls before being removed. Also Read | Watch: Jaiswal Sledges Konstas with 'Shot Nahi Lag Rahe Kya' Kingma's case continues a recent pattern of recreational drug offenses for international cricket. South Africa's Kagiso Rabada and New Zealand's Doug Bracewell have each received bans for recreational drug use over the past year. In each instance, the original three-month bans were lowered to one month after the players completed ICC-approved treatment programs successfully. Rabada had confessed to returning a positive for recreational drugs and was provisionally suspended, resulting in his premature departure from IPL 2025 on April 3. Bracewell was also provisionally suspended without protest on April 11 after an in-competition sample on January 13 during a Super Smash match between Wellington Firebirds and Central Stags at Wellington yielded an adverse analytical result. The ICC remains serious about recreational drug use while providing avenues for rehabilitation. Kingma's case points out both the stringent anti-doping controls in place and the possibility for players to mitigate suspensions through authorized treatment programs.